Loss of Transforming Growth Factor Beta Signaling in Aortic Smooth Muscle Cells Causes Endothelial Dysfunction and Aortic Hypercontractility. Issue 6 (15th April 2021)

• Record Type: Journal Article
• Authors: Zhu, Jay; Angelov, Stoyan; Alp Yildirim, Ilkay; Wei, Hao; Hu, Jie Hong; Majesky, Mark W.; Brozovich, Frank V.; Kim, Francis; Dichek, David A.
• Is Part Of: Arteriosclerosis, thrombosis, and vascular biology. Volume 41:Issue 6(2021)
• Page Start: 1956
• Page End: 1971
• Publication Date: 2021-04-15
• Subjects: aorta -- endothelium -- mice -- myography -- transforming growth factor beta; Arteriosclerosis -- Periodicals; Thrombosis -- Periodicals; Blood-vessels -- Pathophysiology -- Periodicals; Electronic journals; 616.13
• DOI: 10.1161/ATVBAHA.121.315878
• Languages: English
• ISSNs: 1079-5642

Abstract

Abstract : Supplemental Digital Content is available in the text. Abstract : Objective: Humans and mice with loss-of-function variants of genes in the TGF-β (transforming growth factor beta) signaling pathway develop aortic aneurysms. These aneurysms could be caused by decreased aortic smooth muscle cell (SMC) contractile-protein levels and impaired aortic SMC contractile-unit function. Accordingly, we investigated whether loss of SMC TGF-β signaling in mice alters aortic contractile-protein levels and aortic contractility. Approach and Results: We used immunoblotting, wire myography, histological analyses, and measurements of aortic nitric oxide and superoxide levels to assess aortic contractile-protein levels and vasomotor function in mice with SMC-specific deletion of the type 2 TGF-β receptor (TBR2 SMΔ mice). Aortic contractile-protein levels were not altered in TBR2 SMΔ mice. Surprisingly, TBR2 SMΔ mice had increased aortic contractility and severe endothelial dysfunction. Endothelial dysfunction was manifested as decreased relaxation to acetylcholine (Emax 37% versus 97%; P <0.0001), decreased aortic nitric oxide (50%; P =0.005), decreased endothelial nitric oxide synthase activation (31%; P =0.002), and lower aortic levels of phosphorylated vasodilator-stimulated phosphoprotein (an indicator of nitric oxide bioavailability: 65%; P <0.0001). Aortic hypercontractility was reduced by mechanical denudation of endothelium and was eliminated by pretreatment of TBR2 SMΔ and control aortas with a nitric oxide synthase inhibitor, revealing a significant positive interaction between aortic hypercontractility and absence of endothelium-derived nitric oxide ( P <0.05 for both denudation and nitric oxide inhibition). Conclusions: Aortic aneurysms that develop in TBR2 SMΔ mice are not caused by decreased SMC contractility. Loss of physiological SMC TGF-β signaling causes endothelial dysfunction leading to aortic hypercontractility. Endothelial dysfunction may contribute to vascular pathologies associated with abnormal TGF-β signaling.